Online / Physical Event

18th World Congress on

ALZHEIMERS AND DEMENTIA

Theme: Being Alive is simply about remembering & finding our life what if we are losing our memory

Event Date & Time

Event Location

Zurich, Switzerland

Brochure Program Abstract Registration ReaderBase Awards

20 Years Of Excellence in Scientific Events

RENOWNED/PREVIOUS SPEAKERS

Tracks & Key Topics

Tracks

Academic Key Topics

More

Business Key Topics

More

Alzheimers-Dementia 2023

About Conference

The upcoming "World Congress on Alzheimer’s and Dementia," organized by EuroSciCon and scheduled to be held in Zurich, Switzerland on November 17-18, 2023, is poised to address critical issues surrounding Alzheimer's and dementia. The urgency of this matter stems from its profound implications for the well-being of future generations. The event warmly welcomes a diverse array of participants, including business leaders, industrialists, neurologists, consultants, researchers, professors, physicians, directors, association members, pharmaceutical professionals, and industrial experts, all of whom share a deep interest in the field of neuroscience.

The conference program encompasses participant workshops, enlightening talks, engaging symposia, and ample networking opportunities. Notably, professionals like neurologists, neurosurgeons, psychiatrists, and neuroscientists are encouraged to become global members of EuroSciCon, which offers them exclusive registration discounts. This event is a unique opportunity for experts and authorities in Alzheimer's and dementia to converge in Zurich, Switzerland from November 17-18, 2023, fostering an environment that keeps pace with the dynamic progress in this vital field.

The conference is tailored to a wide spectrum of attendees, including distinguished academics in neuroscience and neurology, brain researchers, healthcare practitioners, public health specialists, dedicated scientists, academic scholars, industry analysts, and researchers. The primary aim of this gathering is to catalyze fresh perspectives on treatment methodologies that promise to have a positive impact on an array of brain disorders. For advertisers and sponsors, this international event offers an exceptional platform to showcase their offerings and contribute to the advancement of our shared goal – enhancing the quality of life on a global scale.

 

 

SESSIONS AND TRACKS

SESSIONS AND TRACKS - ALZHEIMERS DISEASE AND DEMENTIA

1. Alzheimer's Disease Overview

  • Alzheimer's disease is the most common form of dementia, characterized by memory loss and cognitive impairments affecting daily life.
  • Risk factors include increasing age, and it's not limited to elderly individuals.

2. Behavioral Problems in Alzheimer's Disease

  • Alzheimer's disrupts memory and cognition, leading to behavioral and mental symptoms.
  • Personality changes, irritability, anxiety, depression, and more can occur.
  • Symptoms progress to disturbances in sleep, agitation, hallucinations, and delusions.

3. Frontotemporal Dementia

  • Nerve cell damage causes loss of function in brain regions, affecting behavior and motor skills.
  • Different disorders under this category involve proteins tau and TDP4.

4. Vascular Dementia

  • Dementia due to blood supply issues causing cognitive decline over time.
  • Symptoms include confusion, disorientation, speech and vision problems.

5. Mixed Dementia

  • Multiple types of dementia coexist, such as Alzheimer's, vascular dementia, and Lewy body dementia.
  • Different brain changes and regions are involved in mixed dementia cases.

6. Lewy Body Dementia

  • Lewy body dementia is a progressive type of dementia, involving protein deposits in brain cells.
  • Symptoms include cognitive decline, visual hallucinations, and Parkinson's-like motor symptoms.

7. Alzheimer's Disease Pathogenesis and Mechanism

  • Alzheimer's disease is characterized by amyloid-beta plaques and neurofibrillary tangles.
  • Abnormal tau phosphorylation and neurotransmitter imbalances contribute to cognitive decline.

8. Clinical Trials on Alzheimer's Disease

  • Ongoing research includes preclinical investigations, clinical studies, and quality of life trials.
  • Focus on developing treatments and improving patient outcomes.

9. Alzheimer's Disease Causes

  • Brain cell deterioration leads to plaques and tangles, causing memory loss and cognitive decline.
  • Behavioral changes like irritability, distrust, and delusions may emerge.

10. Alzheimer's Care Practice

  • Alzheimer's affects brain function, leading to changes in personality and behavior.
  • Understanding and coping with these changes is essential.

11. Drug Development in Dementia

  • Focus on developing medications targeting Alzheimer's pathology.
  • Cholinesterase inhibitors and other compounds are being explored.

12. Management of Dementia

  • Early diagnosis and effective management improve patient outcomes.
  • Cognitive and neurological assessments, imaging, and support for families are essential.

13. Nursing Care in Dementia

  • Elderly patients with dementia have unique care needs.
  • Encouraging exercise, socialization, and mental stimulation is crucial.

14. Recent Advancements in Dementia

  • Advances in mental therapies and clinical assessment are showing promise.
  • Amyloid imaging, PET scans, and other techniques contribute to better understanding.

15. Neuroimaging in Dementia and Alzheimer's

  • Brain imaging techniques offer insights into brain structure, function, and pathology.
  • Amyloid and tau imaging, SPECT imaging, EEG, and MRI spectroscopy are used.

16. Biomarkers for Dementia

  • Biomarkers provide insight into disease progression, aiding diagnosis and treatment.
  • Cerebrospinal fluid markers, genetic testing, and imaging play crucial roles.

17. Animal Models for Dementia Research

  • Animal models help study dementia pathophysiology and evaluate treatments.
  • Transgenic animals producing abnormal proteins contribute to research.

18. Therapeutic Approach Towards Dementia

  • Current therapies aim to slow cognitive decline and improve symptoms.
  • Cholinergic agents, anti-inflammatory agents, and other strategies are explored.

19. Risk Factors and Prevention

  • Modifiable and non-modifiable risk factors influence dementia development.
  • Lifestyle choices like exercise, diet, and alcohol consumption play a role.

20. Prognosis of Dementia

  • Survival and progression of dementia vary among individuals.
  • Neurological changes and cognitive impairment are central to prognosis.

21. Insulin Resistance on Development of Dementia

  • Link between Alzheimer's and diabetes; insulin resistance plays a role.
  • Understanding insulin dysfunction at a molecular level is crucial.

22. Current Research and Strategies

  • Pharmacotherapies for Alzheimer's are based on amyloid hypothesis.
  • Various drugs and interventions target cognitive impairment and disease progression.

23. Neurodegeneration and Genetics

  • Genetic defects contribute to neurodegenerative disorders.
  • Understanding genetic underpinnings aids in disease research.

24. Amyloid Protein in Dementia

  • Amyloid plaques and neurofibrillary tangles are hallmarks of Alzheimer's.
  • Research links abnormal amyloid to dementia development.

25. Neurosurgery

  • Neurosurgery involves brain and spinal cord interventions.
  • Various techniques and tools are used for neurosurgical procedures.

26. Marketing Strategies of Dementia

  • Alzheimer's Association leads in Alzheimer's research and support.
  • A strategic plan aims to advance Alzheimer's research and care.

Please note that the provided information has been synthesized and condensed for clarity.

Top of Form

 

 

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!